Marketing-authorisation holder · Denmark
H. Lundbeck A/S
109 medicines in 7 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Denmark
109 medicines in 7 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 109
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Brintellix | Vortioxetine | EU (EMA) | Authorised | 2013 |
| BRINTELLIXCompressa rivestita con film | Vortioxetine | Italy | Authorised | |
| Brintellix 10 mg comprimidos recubiertos con pelicula12,710 mg · Comprimido recubierto con película | Vortioxetine | Spain | Marketed | 2014 |
| Brintellix 10 mg, filmomhulde tablettenFilmomhulde tablet | Vortioxetine | Netherlands | Authorised | 2013 |
| BRINTELLIX 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA19,065 mg · Comprimido recubierto con película | Vortioxetine | Spain | Marketed | 2018 |
| BRINTELLIX 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA15 mg · Comprimido recubierto con película | Vortioxetine | Spain | Authorised | 2024 |
| Brintellix 15 mg, filmomhulde tablettenFilmomhulde tablet | Vortioxetine | Netherlands | Authorised | 2013 |
| Brintellix 20 mg comprimidos recubiertos con pelicula25,420 mg · Comprimido recubierto con película | Vortioxetine | Spain | Marketed | 2014 |
| BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Vortioxetine | Spain | Marketed | 2026 |
| BRINTELLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Vortioxetine | Spain | Authorised | 2024 |
| Brintellix 20 mg, filmomhulde tablettenFilmomhulde tablet | Vortioxetine | Netherlands | Authorised | 2013 |
| Brintellix 20 mg/ml druppels voor oraal gebruik, oplossingDruppels voor oraal gebruik, oplossing | Vortioxetine | Netherlands | Authorised | 2013 |
| BRINTELLIX 20 MG/ML GOTAS ORALES EN SOLUCION26.040 mg · Gotas orales en solución | Vortioxetine | Spain | Marketed | 2019 |
| Brintellix 5 mg comprimidos recubiertos con pelicula6,355 mg · Comprimido recubierto con película | Vortioxetine | Spain | Marketed | 2014 |
| Brintellix 5 mg, filmomhulde tablettenFilmomhulde tablet | Vortioxetine | Netherlands | Authorised | 2013 |
| CIPRALEXCompressa rivestita con film | Escitalopram | Italy | Authorised | |
| Cipralex 10 mg filmom obložene tabletefilmom obložena tableta | Escitalopram | Croatia | Marketed | 2026 |
| CIPRALEX 10mg comprimidos recubiertos con pelicula12,77 mg · Comprimido recubierto con película | Escitalopram | Spain | Authorised | 2015 |
| CLOPIXOL DEPOT 200 MG/ML SOLUCION INYECTABLE200 mg · Solución inyectable | Zuclopenthixol | Spain | Marketed | 2025 |
| CLOPIXOL DEPOT 200 MG/ML SOLUCION INYECTABLE200 mg · Solución inyectable | Zuclopenthixol | Spain | Marketed | 2025 |
| EBIXACompressa rivestita con film | Memantine | Italy | Authorised | |
| Ebixa | Memantine | EU (EMA) | Authorised | 2002 |
| EBIXA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10 mg · Comprimido recubierto | Memantine | Spain | Authorised | 2002 |
| EBIXA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10 mg · Comprimido recubierto | Memantine | Spain | Authorised | 2002 |
| EBIXA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10 mg · Comprimido recubierto | Memantine | Spain | Authorised | 2002 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 38 | 37 | 1 | CompaniesAll medicines |
| Saudi Arabia | 25 | 25 | 0 | CompaniesAll medicines |
| Netherlands | 21 | 21 | 0 | CompaniesAll medicines |
| Romania | 11 | 0 | 11 | CompaniesAll medicines |
| Italy | 6 | 6 | 0 | CompaniesAll medicines |
| European Union (EMA) | 5 | 4 | 1 | CompaniesAll medicines |
| Croatia | 3 | 3 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Other companies in the same group.
Ranked by their number of medicines.